An honest comparison
Bariatric Surgery vs Ozempic / Wegovy (Semaglutide)
Bariatric Surgery and Ozempic / Wegovy (Semaglutide) are both medically established interventions for severe obesity — and the choice between them is genuinely consequential. Bariatric surgery has decades of long-term outcome data and produces the most durable weight loss in the literature. GLP-1 drugs are newer, less invasive, and produce strong short-term effects but are dependent on continued treatment. Both deserve serious consideration when BMI exceeds the lifestyle-only threshold.
At a glance
| Metric | Bariatric Surgery | Ozempic / Wegovy (Semaglutide) |
|---|---|---|
| Sustainability | 8/10 | 6/10 |
| Short-term effect | 10/10 | 9/10 |
| Long-term effect | 8/10 | 7/10 |
| Cost / month | Free | ~$1100 |
| Visible results | ~14 days | ~28 days |
| Evidence quality | strong | strong |
Who should pick Bariatric Surgery
Bariatric Surgery is right for adults with BMI ≥40 (or ≥35 with significant comorbidity), willing to commit to lifelong nutritional follow-up and supplementation, and seeking the most durable long-term outcome documented in the literature. The 10-20 year mortality data is unmatched.
Who should pick Ozempic / Wegovy (Semaglutide)
Ozempic / Wegovy (Semaglutide) is right for adults with BMI ≥30 plus comorbidity who want a non-surgical option, who can commit to indefinite treatment, and who can support the muscle and bone changes with resistance training and adequate protein.
The honest verdict
For severe obesity (BMI ≥40), bariatric surgery has the strongest long-term evidence — it's not for everyone but its 60-70% maintenance of weight loss at 10+ years is unmatched. GLP-1 drugs are dramatically less invasive and more accessible, with strong short-term efficacy, but require lifelong treatment and have less long-term safety data. The honest sequencing: try GLP-1 first if BMI is in the 30-40 range; consult a bariatric surgeon if BMI exceeds 40 or if GLP-1 fails over 12+ months.
Why both might fail you (and what to do instead)
Both fail when treated as standalone interventions. Bariatric surgery requires lifelong dietary change and supplementation; GLP-1 requires lifelong drug exposure plus active muscle and bone preservation. Neither addresses sleep, stress, or food environment — those remain critical regardless of intervention.
Free · 2 minutes
Still not sure which fits?
The Metabolic Damage Assessment maps your profile to a starter protocol matched to your specific patterns — not a generic comparison.